HU
Humacyte, Inc. Warrant (HUMAW)
NASDAQ·Healthcare·Biotechnology
$0.03
-26.88%
Mkt Cap $152.87M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$240.35
Range $163.02 – $282.15
Implied Upside
+825845.0%
Consensus $240.35 vs current $0.03